Back to Agenda
The Next Frontier: Autoimmune Cell & Gene Therapy, Regulation, and Patient Access
Learning Objective : After this session, participants will be able to identify how patient advocacy can shape regulatory strategy and access for future autoimmune CGTs, evaluate approaches to incorporating patient priorities such as quality of life and treatment burden into trial design, and discuss strategies to ensure equitable and sustainable patient access.
Speaker(s)
The Next Frontier: Autoimmune Cell & Gene Therapy, Regulation, and Patient Access
Samantha Roberts, PHD
AstraZeneca, United States
Senior Director, Regulatory Intelligence
Have an account?